debt
confidence high
sentiment neutral
materiality 0.75
Nuo Therapeutics closes $325,000 Second Funding, reaching $2,000,000 total loan funding
Nuo Therapeutics, Inc.
- Nuo Therapeutics received the $325,000 Second Funding on October 6, 2026, bringing aggregate Lender funding under the Loan Agreement to $2,000,000.
- The Second Closing Date was moved from September 30 to October 6, 2026 via an Assignment, Joinder, and Amendment No. 1.
- Scott M. Pittman, a director and >10% beneficial owner, assumed $25,000 and received warrants for 4,500 shares, 458 prepayment shares, and up to 2,750 interest shares.
- Second Notes bear 12% annual interest, mature December 31, 2028, and Assuming Lenders received warrants for 18,000 shares plus 1,832 prepayment shares.
- Three new unaffiliated lenders joined, and four Assuming Lenders took the assigned $100,000 Second Funding commitment in equal $25,000 portions.